Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal stu...
Strides Pharma Science has received an Establishment Inspection Report from the United States Food and Drug Administrati...
Orasis Pharmaceuticals and Aspen Australia have announced submission of a New Drug Application in Australia for BESKA, p...
Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
Reporting on ground from API China 2026, BioSpectrum Asia observed growing industry attention around the Middle East and...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
Reporting on ground from API China 2026, BioSpectrum Asia observed a strong strategic focus on the f...
China’s pharmaceutical industry is rapidly advancing towards intelligent manufacturing ecosystems, with smart phar...
The opening session of the 2026 Pharmaceutical Innovation And Compliance Development Forum,...
API China 2026 was officially inaugurated today alongside co located industry exhibitions including PharmChina 2026, NHN...
In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...
India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
India-based Morepen Laboratories, a global leader in Active Pharmaceutical Ingredient (API) manufacturing, has received ...
Patent cliffs will be one of the originator's biggest pain points in the next 3-5 years. Between the originator and bios...
By 2030, pharmaceutical companies are expected to lose over $236 billion in revenue due to the impending ‘patent c...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, ...
Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...
Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...
How did the company perform during FY 2022-23? The company is currently in a recovery phase following the impact ...
